Reports for SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Shortage reports
Actual shortage:
0 (0%)
Anticipated shortage:
0 (0%)
Avoided shortage:
0 (0%)
Resolved:
7 (100%)
7
Discontinuation Reports
To be discontinued:
0
Discontinued:
0
Reversed:
0
0
5 (71%)
0 (0%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ABSORICA LD | 8MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206725 |
| ABSORICA LD | 16MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206731 |
| ABSORICA LD | 16MG | CAPSULE | Resolved | 2025-02-10 | 2025-03-06 | 250073 |
| ABSORICA LD | 24MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206728 |
| ABSORICA LD | 32MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206734 |
| CEQUA | 0.09% | SOLUTION | Resolved | 2021-11-15 | 2022-01-19 | 149218 |
| CEQUA | 0.09% | SOLUTION | Resolved | 2022-06-27 | 2022-07-05 | 163527 |
Showing 1 to 7 of 7
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0